These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

933 related items for PubMed ID: 23780685

  • 1. MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).
    Jiao X, Zhao L, Ma M, Bai X, He M, Yan Y, Wang Y, Chen Q, Zhao X, Zhou M, Cui Z, Zheng Z, Wang E, Wei M.
    Breast Cancer Res Treat; 2013 Jun; 139(3):717-30. PubMed ID: 23780685
    [Abstract] [Full Text] [Related]

  • 2. MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2).
    Ma MT, He M, Wang Y, Jiao XY, Zhao L, Bai XF, Yu ZJ, Wu HZ, Sun ML, Song ZG, Wei MJ.
    Cancer Lett; 2013 Oct 01; 339(1):107-15. PubMed ID: 23879965
    [Abstract] [Full Text] [Related]

  • 3. miR-302a/b/c/d cooperatively inhibit BCRP expression to increase drug sensitivity in breast cancer cells.
    Wang Y, Zhao L, Xiao Q, Jiang L, He M, Bai X, Ma M, Jiao X, Wei M.
    Gynecol Oncol; 2016 Jun 01; 141(3):592-601. PubMed ID: 26644266
    [Abstract] [Full Text] [Related]

  • 4. Co-expression of cytokeratin 8 and breast cancer resistant protein indicates a multifactorial drug-resistant phenotype in human breast cancer cell line.
    Liu F, Fan D, Qi J, Zhu H, Zhou Y, Yang C, Zhu Z, Xiong D.
    Life Sci; 2008 Sep 26; 83(13-14):496-501. PubMed ID: 18725232
    [Abstract] [Full Text] [Related]

  • 5. [Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells].
    Zhang YH, Li G, Yu J, Xu MS, Liu ZX.
    Zhonghua Zhong Liu Za Zhi; 2011 Sep 26; 33(9):654-60. PubMed ID: 22340044
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells.
    Pan YZ, Morris ME, Yu AM.
    Mol Pharmacol; 2009 Jun 26; 75(6):1374-9. PubMed ID: 19270061
    [Abstract] [Full Text] [Related]

  • 7. Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells.
    Zhang Y, Wang H, Wei L, Li G, Yu J, Gao Y, Gao P, Zhang X, Wei F, Yin D, Zhou G.
    Breast Cancer Res Treat; 2010 Oct 26; 123(3):679-89. PubMed ID: 19967559
    [Abstract] [Full Text] [Related]

  • 8. Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells.
    Wang QP, Wang Y, Wang XD, Mo XM, Gu J, Lu ZY, Pan ZL, Zhu YX.
    Int J Biochem Cell Biol; 2013 Sep 26; 45(9):2036-44. PubMed ID: 23838170
    [Abstract] [Full Text] [Related]

  • 9. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).
    Doyle L, Ross DD.
    Oncogene; 2003 Oct 20; 22(47):7340-58. PubMed ID: 14576842
    [Abstract] [Full Text] [Related]

  • 10. Developing multidrug-resistant cells and exploring correlation between BCRP/ABCG2 over-expression and DNA methyltransferase.
    Ji N, Yuan J, Liu J, Tian S.
    Acta Biochim Biophys Sin (Shanghai); 2010 Dec 20; 42(12):854-62. PubMed ID: 21106767
    [Abstract] [Full Text] [Related]

  • 11. Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2.
    Imai Y, Ishikawa E, Asada S, Sugimoto Y.
    Cancer Res; 2005 Jan 15; 65(2):596-604. PubMed ID: 15695404
    [Abstract] [Full Text] [Related]

  • 12. The phytoestrogen genistein enhances multidrug resistance in breast cancer cell lines by translational regulation of ABC transporters.
    Rigalli JP, Tocchetti GN, Arana MR, Villanueva SS, Catania VA, Theile D, Ruiz ML, Weiss J.
    Cancer Lett; 2016 Jun 28; 376(1):165-72. PubMed ID: 27033456
    [Abstract] [Full Text] [Related]

  • 13. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y, Xu K, Yagüe E.
    Breast Cancer Res Treat; 2015 Jun 28; 151(2):269-80. PubMed ID: 25900794
    [Abstract] [Full Text] [Related]

  • 14. Reversal of breast cancer resistance protein (BCRP/ABCG2)-mediated drug resistance by novobiocin, a coumermycin antibiotic.
    Shiozawa K, Oka M, Soda H, Yoshikawa M, Ikegami Y, Tsurutani J, Nakatomi K, Nakamura Y, Doi S, Kitazaki T, Mizuta Y, Murase K, Yoshida H, Ross DD, Kohno S.
    Int J Cancer; 2004 Jan 01; 108(1):146-51. PubMed ID: 14618629
    [Abstract] [Full Text] [Related]

  • 15. Decreased NMIIA heavy chain phosphorylation at S1943 promotes mitoxantrone resistance by upregulating BCRP and N-cadherin expression in breast cancer cells.
    Li K, Li T, Niu Y, Gao Y, Shi Y, He Y, Zhang X, Wang Y, Cao J, Hu X, Chen M, Shi R.
    Biochem Cell Biol; 2024 Jun 01; 102(3):213-225. PubMed ID: 38190650
    [Abstract] [Full Text] [Related]

  • 16. (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line.
    Farabegoli F, Papi A, Bartolini G, Ostan R, Orlandi M.
    Phytomedicine; 2010 Apr 01; 17(5):356-62. PubMed ID: 20149610
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of efflux transporter ABCG2/BCRP does not restore mitoxantrone sensitivity in irinotecan-selected human leukemia CPT-K5 cells: evidence for multifactorial multidrug resistance.
    Su Y, Lee SH, Sinko PJ.
    Eur J Pharm Sci; 2006 Oct 01; 29(2):102-10. PubMed ID: 16844360
    [Abstract] [Full Text] [Related]

  • 18. Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines.
    Ross DD, Yang W, Abruzzo LV, Dalton WS, Schneider E, Lage H, Dietel M, Greenberger L, Cole SP, Doyle LA.
    J Natl Cancer Inst; 1999 Mar 03; 91(5):429-33. PubMed ID: 10070941
    [Abstract] [Full Text] [Related]

  • 19. Gefitinib ("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance.
    Nakamura Y, Oka M, Soda H, Shiozawa K, Yoshikawa M, Itoh A, Ikegami Y, Tsurutani J, Nakatomi K, Kitazaki T, Doi S, Yoshida H, Kohno S.
    Cancer Res; 2005 Feb 15; 65(4):1541-6. PubMed ID: 15735043
    [Abstract] [Full Text] [Related]

  • 20. Glucosamine attenuates drug resistance in Mitoxantrone-resistance breast cancer cells.
    Valinezhad Sani F, Palizban A, Mosaffa F, Jamialahmadi K.
    J Pharm Pharmacol; 2021 Jun 08; 73(7):922-927. PubMed ID: 33885909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.